Clinical Trial Update: A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease [Phase 3]

View source ↗

Summary

Phase 3 trial update for Dimebon in mild-to-moderate Alzheimer's disease; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Dimebon (latrepirdine)

Snippet

Sponsor: Pfizer | Conditions: Alzheimer's Disease | Phase 3 | Status: COMPLETED | Results posted: 2013-02-08